Helios Health Institute GmbH
22
8
9
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
13.6%
3 terminated/withdrawn out of 22 trials
72.7%
-13.8% vs industry average
5%
1 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
REpeat Intervention For Failed Surgical BioProsthEtic AorTic Valves (REPEAT)
Role: collaborator
Early Catheter-directed Treatment of High Risk Pulmonary Embolism
Role: collaborator
German Cardiac Arrest Registry
Role: collaborator
Prediction of Blood Pressure Outcomes Following Renal Denervation (PREDICT-RDN)
Role: collaborator
Remote Ischemic Conditioning With Local Ischemic Postconditioning in High-Risk ST-elevation Myocardial Infarction
Role: lead
Extracorporeal Life Support in Cardiogenic Shock
Role: lead
Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis
Role: lead
Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses
Role: lead
The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases
Role: lead
The Leipzig TAVI Registry
Role: lead
Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes
Role: lead
Smart Watch iECG for the Detection of Cardiac Arrhythmias
Role: lead
Prevalence and Predictors of Esophageal Thermal Lesions in High-power-Short-duration Ablation of Atrial Fibrillation
Role: lead
Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart Failure
Role: lead
Reducing Recurrence of Symptomatic Atrial Fibrillation After Catheter Ablation by App-based Mental Training
Role: lead
Personalised Risk scOre For Implantation of Defibrillators in Patients With Reduced LVEF≤35% and a Low Risk for Sudden Cardiac Death
Role: lead
Personalised Risk scOre For Implantation of Defibrillators in Patients With Preserved LVEF>35% and a High Risk for Sudden Cardiac Death
Role: lead
Effect of Multielectrode Versus Point-by-Point Mapping on Recurrence of Ventricular Tachycardia in Ischemic Heart Disease
Role: lead
Randomized Comparison of Catheter-based Strategies for Interventional Access Site Closure During Transfemoral Transcatheter Aortic Valve Implantation
Role: lead
Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contractions in Patients With Structural Heart Disease
Role: collaborator